Pleno rais­es $25M for mul­ti­omics test­ing, names new CEO

Pleno has raised an ad­di­tion­al $25 mil­lion in pri­vate fund­ing to ad­vance its tests that de­tect bi­o­log­i­cal tar­gets for drug re­search and di­ag­nos­tics.

The com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER